Akebia Therapeutics Stock News

Akebia Therapeutics (AKBA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

BMW Group Malaysia has revised the prices of its BMW, Mini and BMW Motorrad products to exclude the sales tax on all completely knocked-down (CKD) models for the period of June 15 to Dec 31, 2020. Thi

Gubernur Jawa Barat Ridwan Kamil (Kang Emil) mengapresiasi penerapan adaptasi kebiasaan baru (AKB) atau normal baru di objek wisata Pangandaran, sehingga bisa ...

Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that data from an investigational clini

A new expert-led report has today been launched to help outline key challenges and inequalities in the care of type 2 diabetes mellitus (T2DM) and its

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase

Gubernur Jawa Barat (Jabar) yang juga Ketua Gugus Tugas Percepatan Penanggulangan COVID-19 Jabar M Ridwan Kamil  mengemukakan lima tahap adaptasi normal ...

The

Akebia has taken a significant step towards securing approval for Vadadustat, its potential blockbuster treatment for anemia in CKD sufferers. Data from the pha

Q1 2020 Akebia Therapeutics Inc Earnings Call